Latest News

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

When Treasury Secretary Bessent’s latest bond buyback plan failed to tame long-term yields, it sharpened investor focus on debt, deficits above $2t, and what that might mean for assets tied to gold and precious metals. Rising questions about U.S. fiscal credibility and policy firepower are already showing up in markets. This article looks at three gold linked miners from our screener that appear particularly exposed to this shift, and why their stories deserve attention now. The three stocks...

Fiserv (FISV) is back in focus after its Q2 earnings showed a 4.5% year on year revenue decline and a significant miss versus analyst expectations, prompting a sharp negative reaction in the stock. Against that earnings backdrop, Fiserv’s recent price action tells a cautious story. The share price return is down 18.9% year to date and about 10% over the past 90 days, while the 1 year total shareholder return has declined 61.5%, pointing to fading momentum as investors reassess growth and...

Garrett Motion recently reported its second-quarter 2026 results, posting earnings of US$0.53 per share and 6.9% year-on-year net sales growth, while also lifting its full-year outlook for net sales, adjusted EBIT, and free cash flow. Alongside the stronger guidance, the company highlighted progress in commercial vehicle electric powertrain and industrial air compression programs, signaling an increasing emphasis on technologies beyond traditional light-vehicle turbochargers. Next, we’ll...

Why CTS Stock Is Back On Investor Radar After Its Distribution Move CTS (CTS) has drawn fresh attention after announcing that its current sensing solutions will now be sold through authorized distribution partners serving a wide range of non automotive, high growth end markets. CTS shares have pulled back recently, with the 30 day share price return down 11.77% and the 90 day share price return down 11.46%, even though the year to date share price return is 29.01% and the 1 year total...

General Mills stock has had a tough few years, with the share price still well below where it was three years ago even after a recent rebound. For investors, the question is whether a company widely viewed as fairly valued on earnings multiples but carrying a low overall value score really offers enough compensation for that past share price weakness. Over the past three years, General Mills shareholders have seen the stock decline about 28%, which sets a cautious backdrop despite the recent...

CRISPR Therapeutics stock has had a strong shorter term recovery, yet longer term holders are still sitting on a large loss, and current valuation checks lean more toward an expensive reading than a clear bargain. The share price is down about 52.7% over 5 years, which means many longer term investors are still under water even after more recent gains. Fresh Phase 1a data for CTX310 presented at the ESC Congress 2026 may support confidence in CRISPR Therapeutics drug pipeline, while clinical...

GL-Carlink Technology Holding closed today at HK$4.88 after earnings landed with a thud rather than a spark. The stock has drifted lower over the past month while the latest half year numbers confirmed what many feared. The headline is not revenue; it is the swing into a deeper loss. Basic earnings per share for the first half of 2026 came in at a loss of C¥0.12, with net income also in the red. For a software stock that had been profitable as recently as 2025, that reversal is what is really...

Apple (NasdaqGS:AAPL) adjusts pricing for its Apple TV+ and Apple One subscription bundles, increasing monthly costs for users across several tiers. The company introduces a Klarna-backed device leasing option that lets customers spread payments on Apple hardware over time. Apple experiences memory chip supply constraints as global AI demand tightens component availability for upcoming products. Independent patent reviews identify Apple as a leader in AI smart glasses filings, even without a...

Shares of NovoCure (NVCR) have moved higher recently after analysts raised earnings estimates, with short term targets pointing to about 50.9% potential upside and a Zacks Rank #2 reflecting this sentiment. NovoCure’s recent momentum has been building, with a 30 day share price return of 20.08% and a year to date share price return of 35.82%. The 1 year total shareholder return of 44.53% contrasts with weaker total shareholder returns over three and five years. Compare NovoCure's recent...

Global inflation pressures are keeping central banks wary, which keeps borrowing costs and growth expectations in focus. That uncertainty has pushed more attention onto companies helping businesses cut costs and boost productivity with artificial intelligence. If AI tools can help do more with the same budget, that matters. This article looks at three AI stocks from our screener that tap directly into that theme. The stocks highlighted below are just a starting sample, since the full AI...

Sanofi (ENXTPA:SAN) halted a Phase 3 RSV vaccine trial in infants and toddlers after the death of a participant linked to an undiagnosed congenital heart defect. The company reported an overall acceptable safety profile in the trial with no cases of vaccine associated enhanced respiratory disease identified. The pause has drawn attention to inclusion and exclusion criteria in pediatric vaccine studies and to how closely clinical trial protocols are followed. Regulators and investors are...

QuantumScape stock has delivered a steeply negative long term return, yet the current valuation checks still suggest the shares are not an obvious bargain. For investors trying to make sense of the story today, the share price history, the current multiples and a weak value score all pull in the same cautious direction. Over the past 5 years, QuantumScape has declined about 75%, which points to heavy value erosion for longer term holders. The company’s future equity value can depend heavily...

Spotify Technology (NYSE:SPOT) drew fresh attention on 20 August 2026 after lifting its equity buyback authorization by an additional US$1.5b, prompting investors to reassess how management is thinking about capital allocation. Spotify Technology's latest buyback move comes after a choppy year for the stock, with a 1 month share price return of 9.52% and a 3 month share price return of 7.83%. However, there has been a year to date share price decline of 4.78% and a 1 year total shareholder...

Insperity, Inc. recently reported past second-quarter 2026 results that exceeded earnings and revenue estimates, alongside a quarterly cash dividend declaration of US$0.60 per share payable on September 17, 2026, to stockholders of record as of September 2, 2026. Beyond the dividend, the company’s margin recovery efforts and updated 2026 guidance, built around expense control, HRScale, and AI initiatives, have become central to how investors assess its operational progress. We’ll now examine...

Extreme Networks (NasdaqGS: EXTR) has appointed Deloitte & Touche as its new independent registered public accounting firm. The new appointment replaces Grant Thornton LLP as the company’s external auditor. The change marks a significant development in Extreme Networks’ audit oversight and financial reporting framework. For a wider view on how companies with different governance and reporting setups can affect portfolio resilience, you can compare this move with a broader group of typically...

ARB Corporation Limited has released its full-year results for the period ended June 30, 2026, reporting sales of A$702.02 million, revenue of A$711.54 million, and net income of A$92.41 million, all lower than the prior year, alongside diluted earnings per share from continuing operations of A$1.107. Despite the year-on-year decline in key financial metrics, ARB also declared a fully franked ordinary dividend of A$0.35 per share for the half-year to June 30, 2026, which may prompt investors...

With inflation trends looking less heated on shorter-term measures and rate hike odds cooling from earlier in the year, some growth stocks are suddenly back in focus. If the Federal Reserve steps more carefully from here, investors who waited on the sidelines could feel they moved too slowly. This article walks through three U.S. growth and technology stocks exposed to this shifting rate story and explains why each one may warrant a closer look now. The three stocks below are just a sample...

Palantir Technologies (NasdaqGS:PLTR) is reportedly adjusting its political outreach to build closer ties with Democrats ahead of the upcoming US midterm elections. The company is said to be making substantial donations to Democratic campaigns after earlier support for Republican initiatives. This shift is intended to reduce political and regulatory risk if control of the US House of Representatives changes. Investors are watching how Palantir manages relationships across both parties, as...

Hafnia (OB:HAFNI) is back in focus after reporting Q2 2026 sales of US$505.7 million and net income of US$287.3 million, alongside a US$250 million dividend based on a 90% payout ratio. Hafnia’s strong Q2 update and larger dividend come after a solid run in the stock, with the share price at NOK77.65 and a year to date share price return of 47.79%, alongside a 1 year total shareholder return of 40.38% and a very large 5 year total shareholder return of 7x. Capture Hafnia’s momentum and...

Rising US Treasury yields are keeping borrowing costs in focus, which can pressure highly leveraged companies and fragile penny stocks. That is exactly why the Financially Fit Penny Stocks screener matters right now. It filters for lower priced stocks with stronger balance sheets so you are not just chasing low share prices. This article highlights three screened stocks that aim to balance growth potential with financial discipline. The three stocks below are a sample pulled from a much wider...

News around NICE (TASE:NICE) today centers on Bluecrest Health Intelligence’s move to an AI-enabled contact center model using the CXone platform, highlighting how the company’s technology is being applied in real-world healthcare operations. Despite the Bluecrest win and other recent CXone client additions, momentum in NICE’s share price has been mixed. The company has a 90-day share price return of 12.09%, a year-to-date share price decline of 14.53%, and a 1-year total shareholder return...

Caterpillar’s dividend track record meets a reshaped business mix Caterpillar (CAT) is back in focus after rapid growth in its power generation business, along with strong Construction Industries revenue trends and an 8% quarterly dividend increase that extended a 32 year streak of annual raises. The recent pullback, with the share price down about 7.5% over 90 days and 3.3% over the past week to US$800.25, follows a strong run that has pushed Caterpillar’s year to date share price return to...

Inflation concerns and higher yields keep pressure on energy costs, which keeps attention on reliable power sources that are less exposed to fuel price swings. That is where nuclear energy stocks draw interest. For investors who do not want to sit on the sidelines, this screener highlights nuclear energy stocks across uranium, fuel cycle and reactor operations. This article walks through three stocks from the list that may warrant a closer look. The three nuclear energy stocks discussed below...